Table 13.
Serum YKL-40 levels (ng/ml) in patients with inflammation, tissue remodeling, or fibrosis [201].
| Disease | Median serum YKL-40 (ng/l) | Reference |
|---|---|---|
| Viral hepatitis | 83 | [202] |
| Noncirrhotic fibrosis | 158 | |
| Posthepatitis cirrhosis | 204 | |
| Rheumatoid arthritis | 110 | [203] |
| Streptococcus pneumoniae bacteremia | 342 | [200] |
| Osteoarthritis | 112 | [204] |
| UC, severe | 59 | [205] |
| CD, severe | 59 | |
| Pulmonary sarcoidosis | 201 | [206] |
| Asthma | 92 | [207] |